Loading...

Morishita Jintan Co., Ltd.

4524.TJPX
Healthcare
Drug Manufacturers - Specialty & Generic
¥2200.00
¥2.00(0.09%)

Morishita Jintan Co., Ltd. (4524.T) Financial Performance & Income Statement Overview

Access detailed quarterly and annual financial reports for Morishita Jintan Co., Ltd. (4524.T), covering cash flow, earnings, and balance sheets.

Revenue Growth
2.90%
2.90%
Operating Income Growth
12.29%
12.29%
Net Income Growth
-21.52%
21.52%
Operating Cash Flow Growth
241.33%
241.33%
Operating Margin
4.89%
4.89%
Gross Margin
45.39%
45.39%
Net Profit Margin
4.28%
4.28%
ROE
4.43%
4.43%
ROIC
4.14%
4.14%

Morishita Jintan Co., Ltd. (4524.T) Income Statement & Financial Overview

View the income breakdown for Morishita Jintan Co., Ltd. 4524.T across both annual and quarterly reports.

MetricQ4 2024Q3 2024Q2 2024Q1 2024
Revenue$3.17B$3.21B$2.97B$3.41B
Cost of Revenue$1.70B$1.71B$1.69B$1.88B
Gross Profit$1.47B$1.50B$1.29B$1.53B
Gross Profit Ratio$0.46$0.47$0.43$0.45
R&D Expenses$0.00$0.00$0.00$0.00
SG&A Expenses$1.33B$1.26B$1.36B$1.21B
Operating Expenses$1.33B$1.26B$1.36B$1.22B
Total Costs & Expenses$3.03B$2.97B$3.04B$3.10B
Interest Income$0.00$0.00$0.00$13.00M
Interest Expense$5.00M$1.00M$0.00$0.00
Depreciation & Amortization$151.00M$144.00M$140.50M$144.00M
EBITDA$271.00M$385.00M$68.50M$461.00M
EBITDA Ratio$0.09$0.12$0.02$0.14
Operating Income$139.00M$241.00M-$72.00M$316.00M
Operating Income Ratio$0.04$0.08-$0.02$0.09
Other Income/Expenses (Net)$108.00M$22.00M$5.00M$12.00M
Income Before Tax$247.00M$263.00M-$67.00M$328.00M
Income Before Tax Ratio$0.08$0.08-$0.02$0.10
Income Tax Expense$50.00M$96.00M-$4.00M$83.00M
Net Income$197.00M$168.00M-$63.00M$245.00M
Net Income Ratio$0.06$0.05-$0.02$0.07
EPS$48.15$41.05-$15.41$59.96
Diluted EPS$48.15$41.05-$15.41$59.96
Weighted Avg Shares Outstanding$4.09M$4.09M$4.09M$4.09M
Weighted Avg Shares Outstanding (Diluted)$4.09M$4.09M$4.09M$4.09M

Over the last four quarters, Morishita Jintan Co., Ltd.'s revenue moved from $3.41B in Q1 2024 to $3.17B in Q4 2024. Operating income in Q4 2024 was $139.00M, with a strong operating margin of 4%. Despite fluctuations in R&D and SG&A expenses, EBITDA for Morishita Jintan Co., Ltd. remained robust at $271.00M, reflecting operational efficiency. Net income rose to $197.00M, with an EPS of $48.15. Disciplined expense management helped sustain profitability, highlighting solid overall financial performance.

Unlock 25+ Years of Financial Data

Get access to extended historical data, advanced metrics, and more with our premium plan

Frequently Asked Questions

;